- Home
- Publications
- Publication Search
- Publication Details
Title
Antidementia Medication Use in Nursing Home Residents
Authors
Keywords
-
Journal
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
Volume -, Issue -, Pages -
Publisher
SAGE Publications
Online
2023-09-16
DOI
10.1177/08919887231202948
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative safety and efficacy of cognitive enhancers for Alzheimer’s dementia: a systematic review with individual patient data network meta-analysis
- (2022) Areti Angeliki Veroniki et al. BMJ Open
- Acetyl-cholinesterase-inhibitors slow cognitive decline and decrease overall mortality in older patients with dementia
- (2022) Marco Zuin et al. Scientific Reports
- Effectiveness of Treatments for People Living with Severe Dementia: A Systematic Review and Meta-Analysis of Randomised Controlled Clinical Trials
- (2022) Elena Profyri et al. AGEING RESEARCH REVIEWS
- Donepezil treatment is associated with improved outcomes in critically ill dementia patients via a reduction in delirium
- (2022) Ori J. Lieberman et al. Alzheimers & Dementia
- Effect of Cholinesterase Inhibitors on Mortality in Patients With Dementia: A Systematic Review of Randomized and Nonrandomized Trials
- (2022) Céline Truong et al. NEUROLOGY
- Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality
- (2021) Hong Xu et al. NEUROLOGY
- Validation of Claims Algorithms to Identify Alzheimer’s Disease and Related Dementias
- (2021) Ellen P McCarthy et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Impact of deprescribing AChEIs on aggressive behaviors and antipsychotic prescribing
- (2020) Joshua D. Niznik et al. Alzheimers & Dementia
- Multidisciplinary perspectives on medication-related decision-making for people with advanced dementia living in long-term care: a critical incident analysis
- (2020) Domenica Disalvo et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Resident-Level Predictors of Dementia Pharmacotherapy at Long-Term Care Admission: The Impact of Different Drug Reimbursement Policies in Ontario and Saskatchewan
- (2020) Laura C. Maclagan et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Different Doses of Pharmacological Treatments for Mild to Moderate Alzheimer’s Disease: A Bayesian Network Meta-Analysis
- (2020) Tingting Zhang et al. Frontiers in Pharmacology
- Psychosis in Alzheimer’s Disease
- (2020) Clive Ballard et al. Current Neurology and Neuroscience Reports
- Memantine, Donepezil, or Combination Therapy—What is the best therapy for Alzheimer’s Disease? A Network Meta‐Analysis
- (2020) Jiaxun Guo et al. Brain and Behavior
- Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary
- (2019) Emily Reeve et al. MEDICAL JOURNAL OF AUSTRALIA
- The effect of antidementia drugs on mortality in patients with Alzheimer’s disease
- (2019) Wei-Hao Lin et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease
- (2019) Dan-Dan Li et al. Frontiers in Neuroscience
- Factors Associated With Deprescribing Acetylcholinesterase Inhibitors in Older Nursing Home Residents With Severe Dementia
- (2019) Joshua D. Niznik et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Risk for Health Events After Deprescribing Acetylcholinesterase Inhibitors in Nursing Home Residents With Severe Dementia
- (2019) Joshua D. Niznik et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- A Systematic Review of Practice Guidelines and Recommendations for Discontinuation of Cholinesterase Inhibitors in Dementia
- (2018) Brenna N. Renn et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia
- (2018) Ruth Knight et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- The efficacy and safety of memantine for the treatment of Alzheimer’s disease
- (2018) Shinji Matsunaga et al. Expert Opinion On Drug Safety
- Memantine is Associated with Longer Survival than Donepezil in a Veterans Affairs Prescription Database, 1997 to 2008
- (2018) Laura C. Lazzeroni et al. JOURNAL OF ALZHEIMERS DISEASE
- Predictors of Cholinesterase Discontinuation during the First Year after Nursing Home Admission
- (2018) Laura C. Maclagan et al. Journal of the American Medical Directors Association
- Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer’s disease: a network meta-analysis of 41 randomized controlled trials
- (2018) Kai-Xin Dou et al. Alzheimers Research & Therapy
- Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients
- (2017) Lídia Blanco-Silvente et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
- (2017) John T O’Brien et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Minimum Data Set 3.0 Cognitive Function Scale
- (2017) Kali S. Thomas et al. MEDICAL CARE
- Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies
- (2016) Jeffrey Cummings et al. CNS Neuroscience & Therapeutics
- Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study
- (2016) Daniela Koller et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer’s Disease
- (2015) William James Deardorff et al. DRUGS & AGING
- A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence
- (2015) Jacob S. Buckley et al. DRUGS & AGING
- Cholinesterase Inhibitor Discontinuation in Patients With Alzheimer’s Disease
- (2015) Jordana O’Regan et al. JOURNAL OF CLINICAL PSYCHIATRY
- Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses
- (2015) Robert Howard et al. LANCET NEUROLOGY
- Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer’s dementia: a pooled area under the curve analysis
- (2015) Alireza Atri et al. Alzheimers Research & Therapy
- World Federation of Societies of Biological Psychiatry guidelines for the pharmacological treatment of dementias in primary care
- (2014) Ralf Ihl et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- A 24-Week, Randomized, Controlled Trial of Rivastigmine Patch 13.3 mg/24 h Versus 4.6 mg/24 h in Severe Alzheimer's Dementia
- (2013) Martin R. Farlow et al. CNS Neuroscience & Therapeutics
- Benefits of combined cholinesterase inhibitor and memantine treatment in moderate–severe Alzheimer's disease
- (2012) Serge Gauthier et al. Alzheimers & Dementia
- Guidelines for the Management of Cognitive and Behavioral Problems in Dementia
- (2012) C. H. Sadowsky et al. Journal of the American Board of Family Medicine
- Cholinesterase Inhibitor and Memantine Use in Newly Admitted Nursing Home Residents with Dementia
- (2011) Carole Parsons et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Inappropriate Drug Prescription at Nursing Home Admission
- (2011) Fermín García-Gollarte et al. Journal of the American Medical Directors Association
- Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology
- (2010) John T O’Brien et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Memantine Discontinuation and the Health Status of Nursing Home Residents With Alzheimer's Disease
- (2010) Howard Fillit et al. Journal of the American Medical Directors Association
- Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia
- (2009) Lori A. Daiello et al. American Journal Geriatric Pharmacotherapy
- Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer’s Disease: Systematic Review of the ‘Real-World’ Evidence
- (2009) I.A. Lockhart et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Cholinesterase Inhibitor and N-Methyl-D-Aspartic Acid Receptor Antagonist Use in Older Adults with End-Stage Dementia: A Survey of Hospice Medical Directors
- (2009) Joseph W. Shega et al. JOURNAL OF PALLIATIVE MEDICINE
- Cholinesterase Inhibitor Use in U.S. Nursing Homes: Results from the National Nursing Home Survey
- (2009) Dallas P. Seitz et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Long-term Course and Effectiveness of Combination Therapy in Alzheimer Disease
- (2008) Alireza Atri et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Donepezil Treatment of Patients with Severe Alzheimer’s Disease in a Japanese Population: Results from a 24-Week, Double-Blind, Placebo-Controlled, Randomized Trial
- (2008) Akira Homma et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- The Aggressive Behavior Scale: A New Scale to Measure Aggression Based on the Minimum Data Set
- (2008) Christopher M. Perlman et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now